Fumihiko Hayakawa

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model.

Antithrombotic Therapy on Antithrombin Resistance in a Mouse Model.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: January 08, 2026

von Willebrand factor-T441N, a novel missense variant in the von Willebrand factor D2 domain, exhibits impaired multimerization and deformed Weibel-Palade bodies.

von Willebrand factor-T441N, a novel missense variant in the von Willebrand factor D2 domain, exhibits impaired multimerization and deformed Weibel-Palade bodies.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 12, 2025

Two-way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3.

Two-way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3.

Journal: FEBS open bio

Published: January 24, 2025

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Nelarabine-combined chemotherapy improves outcome of T-cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T-ALL213-O.

Journal: Cancer science

Published: July 11, 2024

JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL.

JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL.

Journal: International journal of hematology

Published: June 30, 2024

Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance.

Misleading antigenic von Willebrand factor levels in acquired von Willebrand syndrome secondary to monoclonal gammopathy of undetermined significance.

Journal: International journal of hematology

Published: June 08, 2024

NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation.

NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation.

Journal: Cancer medicine

Published: January 19, 2024

RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins.

RGS1 and CREB5 are direct and common transcriptional targets of ZNF384-fusion proteins.

Journal: Cancer medicine

Published: January 18, 2024

Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.

Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.

Journal: Oncogene

Published: June 15, 2023

EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.

EBF1-JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity.

Journal: International journal of hematology

Published: December 25, 2022

Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.

Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.

Journal: Cancer science

Published: June 20, 2022

Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.

Oncogenic lesions and molecular subtypes in adults with B-cell acute lymphoblastic leukemia.

Journal: Cancer science

Published: June 14, 2022

Showing 1-12 of 77

Last Updated: 09/26/2026